Veracyte (VCYT)
(Delayed Data from NSDQ)
$32.84 USD
-0.13 (-0.39%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $32.96 +0.12 (0.37%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth A Momentum B VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 24% (61 out of 252)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.92 | 1.66 | 9.99 |
Current Quarter Estimate | 0.02 | 4.84 | 63.00 |
Year Ago Quarter Estimate | -0.03 | 3.53 | 52.25 |
Next Quarter Estimate | 0.07 | 5.68 | 66.00 |
Next Year Estimate | 0.30 | 24.58 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 113.73 | 13.70 | 15.67 |
Next Year | 114.29 | 20.30 | 11.34 |
Last 5 Years | NA | 10.20 | 8.10 |
Next 5 Years | NA | 13.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 156.38 | 8.54 |
Price/Book (MRQ) | 2.22 | 2.36 |
Price/Cash Flow (MRFY) | 353.83 | 19.29 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -13.52% | -27.47% |
Return on Equity (TTM) | 1.52% | -24.27% |
Debt to Equity (MRQ) | NA | 9.17 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.